Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07295925

Risk Factors for Postoperative Fever and Sepsis Following Retrograde Intrarenal Surgery

This prospective clinical study aims to evaluate preoperative, intraoperative, and postoperative characteristics of patients undergoing retrograde intrarenal surgery (RIRS) for urinary stone disease. A total of approximately 250 patients will be assessed to identify clinical, laboratory, and operative factors associated with postoperative fever and sepsis. By systematically collecting and analyzing perioperative data, the study seeks to determine independent predictors that may support improved risk stratification and patient safety in endourological practice.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Erciyes University Faculty of Medicine, Department of Urology

Kayseri, Melikgazi, 38140, Turkey (Türkiye)

Location contact

Emre C. Akınsal, Assoc. Prof.

CONTACT

[email protected]

+90352 207 66 66 ext. 22107

Emre C. Akınsal, Assoc. Prof.

PRINCIPAL_INVESTIGATOR

Mehmet F. Kesici, M.D.

CONTACT

[email protected]

+90554 661 30 33

Mehmet F. Kesici, M.D.

SUB_INVESTIGATOR

About this study

Urinary stone disease is a common global health problem with an increasing incidence and significant clinical and economic burden. Retrograde intrarenal surgery (RIRS) has become a widely accepted, minimally invasive, and effective treatment option for renal and proximal ureteral stones. Advances in flexible ureteroscope design, laser technologies, and endourological instrumentation have further improved the safety, efficiency, and applicability of RIRS. As a result, there has been a marked increase in the preference for RIRS among urologists in recent years.

Despite its advantages, RIRS is associated with complication rates reported between 9% and 25%. Postoperative fever and urinary tract infection are the most frequently observed complications and may progress to sepsis, which represents a potentially life-threatening condition in patients with urinary stone disease. These infectious events remain a concern even when appropriate antibiotic prophylaxis and aseptic surgical principles are applied. Identifying risk factors that may predict postoperative infection and sepsis is therefore essential for improving perioperative decision-making and patient safety.

Previous studies have suggested potential associations between operative characteristics, preoperative bacteriuria, patient-related comorbidities, and postoperative infectious outcomes; however, most available evidence originates from retrospective analyses with limited variables. There remains a need for prospective, systematically collected data evaluating a broad set of perioperative clinical and laboratory parameters to better define predictive factors.

This prospective patient registry study aims to evaluate comprehensive perioperative variables to identify predictors of postoperative urinary tract infection and sepsis following RIRS. Parameters to be assessed include operative time, stone burden, intraoperative irrigation characteristics, perioperative cultures, and a detailed panel of inflammatory biomarkers such as C-reactive protein, procalcitonin, albumin, fibrinogen, and D-dimer. The study will also record the onset, duration, and severity of postoperative fever, together with other clinical findings relevant to infectious complications. Through this structured approach, the study seeks to determine independent risk factors that may assist clinicians in predicting, preventing, and managing postoperative infection and sepsis in patients undergoing RIRS.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older.
  • Patients scheduled to undergo retrograde intrarenal surgery (RIRS) for the treatment of renal or ureteral stones.
  • Completion of routine preoperative and postoperative clinical assessments required for RIRS.
  • Ability to provide informed consent.

Exclusion criteria

  • Terminal-stage malignancy.
  • Bleeding diathesis or known immunodeficiency.
  • Active infectious condition at the time of surgery.
  • Patients deemed unsuitable for anesthesia or surgery by the Department of Anesthesiology.
  • Pregnancy.
  • Contraindications to RIRS or inability to complete required perioperative evaluations.

Treatment and study plan

Primary outcomes

  1. Number of Participants With Postoperative Sepsis

    Time frame: Within 72 hours after surgery

    Postoperative sepsis will be defined according to Sepsis-3 criteria, based on suspected or confirmed infection and an increase of ≥ 2 points in the Sequential Organ Failure Assessment (SOFA) score within 72 hours after retrograde intrarenal surgery (RIRS).

Secondary outcomes

  1. Number of Participants With Postoperative Fever

    Time frame: Within 72 hours after surgery

    Postoperative fever will be defined as a body temperature ≥38ºC recorded at least twice within 72 hours after retrograde intrarenal surgery (RIRS).

  2. Number of Participants With Systemic Inflammatory Response Syndrome (SIRS)

    Time frame: First 24 hours after surgery

    SIRS will be defined according to standard clinical criteria, including abnormalities in body temperature, heart rate, respiratory rate and leukocyte count after retrograde intrarenal surgery (RIRS).

  3. Number of Participants With Positive Postoperative Urine Culture

    Time frame: Within 72 hours

    Growth of ≥10⁵ CFU/mL of a single organism in a postoperative urine culture.

  4. Number of Participants with Positive Postoperative Blood Culture

    Time frame: Within 72 hours

    Detection of pathogenic microorganisms from blood samples obtained in the postoperative period.

  5. Number of Participants With Positive Stone Culture

    Time frame: Up to 72 hours after surgery

    Presence of bacterial growth in stone culture obtained during retrograde intrarenal surgery (RIRS), defined as any clinically significant pathogen isolated from stone fragments

  6. Length of Hospital Stay (days)

    Time frame: From the date of surgery until hospital discharge, assessed up to 30 days postoperatively.

    Length of hospital stay will be defined as the number of days from the date of surgery to the date of hospital discharge

Study contacts

Contact information is provided by the study sponsor or research team.

Emre C. Akınsal, Assoc. Prof.

CONTACT

[email protected]

+90 352 207 66 66 ext. 22107

Mehmet F. Kesici, M.D.

CONTACT

[email protected]

+90554 661 30 33

Sponsors and collaborators

Lead sponsor

TC Erciyes University

Other

Registry information

Official study title

Prospective Evaluation of Clinical, Laboratory and Operative Predictors of Postoperative Fever and Sepsis After Retrograde Intrarenal Surgery (RIRS)

Acronym: SARIS

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Dec 22, 2025
Registry last updated
Dec 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.